NCT03056599 2021-09-24
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
Presage Biosciences
Phase 1 Completed
Presage Biosciences
Oncovir, Inc.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)